The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CHIASMA INC COM 16706W102 6,439 1,196,776 SH   SOLE   0 0 1,196,776
KURA ONCOLOGY INC COM 50127T109 3,363 206,307 SH   SOLE   0 0 206,307
RUBIUS THERAPEUTICS INC COM 78116T103 15,658 2,618,351 SH   SOLE   0 0 2,618,351
SYROS PHARMACEUTICALS INC COM 87184Q107 4,264 400,000 SH   SOLE   0 0 400,000